(Q44736529)

5 December 2017

Failures of protection by measles vaccine (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80107-6

22 February 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698971

22 February 2023

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698971

22 February 2023

medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698971

22 February 2023

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698971

22 February 2023

1

S A Plotkin

1 reference

5 December 2017

S. A. Plotkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4698971

22 February 2023

language of work or name

English

0 references

publication date

1 May 1973

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0022347673801076?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80107-6

https://api.elsevier.com/content/article/PII:S0022347673801076?httpAccept=text/plain

22 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80107-6

The Journal of Pediatrics

22 February 2023

published in

1 reference

5 December 2017

82

1 reference

5 December 2017

5

1 reference

5 December 2017

908-911

1 reference

The epidemiologic rationale for the failure to eradicate measles in the United States

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Measles in children previously vaccinated against measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Present status of measles and rubella immunization in the United States: a medical progress report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Live, further attenuated rubella vaccine. Serologic responses among term and low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Urban measles in the vaccine era: A clinical, epidemiologic, and serologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

A clinical and serologic study of 103 children with measles vaccine failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Measles IgM response during reinfection of previously vaccinated children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Clinical Epidemiology of Sporadic Measles in a Highly Immunized Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Altered reactivity to measles virus. Skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Skin tests with measles and poliomyelitis vaccines in recipients of inactivated measles virus vaccine. Delayed dermal hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Eight-year serologic evaluation of Edmonston live measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

A seroepidemiologic study of a measles epidemic in a highly immunized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Measles in previously vaccinated children. An epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Epidemic Measles in a Divided City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Vaccination against measles: clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Studies on an attenuated measlesvirus vaccine. IV. Administration of vaccine by several routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

STUDIES ON IMMUNITY TO MEASLES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980107-6

Measles (rubeola) in previously immunized children

7 January 2021

series ordinal

6

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80107-6

22 February 2023

Identifiers

1 reference

5 December 2017

1 reference